AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 10 of 131

11 Summary risk of incident AF Effect of LRFM risk N/A • Hypertension: risk • SBP: risk • DBP: risk • Renal denervation: AF postablation • Mineralocorticoid receptor antagonists (MRAs): AF burden • BP control postablation: • Intensive BP control to SBP <120 mm Hg in patients with HTN at high risk for cardiovascular disease (CVD): AF risk • BP control as part of a comprehensive LRFM program: AF burden • Slow heart rate: variable risk • Higher heart rate: variable risk N/A risk • Optimal glycemic control preablation may AF recurrence postablation

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update